VEA
INBX

Virtus ETF Advisers’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Virtus ETF Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,143
Closed -$110K – 488
2024
Q1 		$110K Sell
3,143
-219
-7% -$7.99K 0.06% 352
2023
Q4 		$128K Sell
3,362
-316
-9% -$6.77K 0.08% 321
2023
Q3 		$67.5K Sell
3,678
-366
-9% -$7.66K 0.04% 390
2023
Q2 		$105K Buy
4,044
+606
+18% +$14.2K 0.06% 357
2023
Q1 		$64.9K Sell
3,438
-1,323
-28% -$30.8K 0.04% 413
2022
Q4 		$117K Sell
4,761
-7,502
-61% -$221K 0.06% 426
2022
Q3 		$220K Buy
12,263
+91
+0.7% +$1.64K 0.09% 310
2022
Q2 		$138K Buy
12,172
+8,204
+207% +$121K 0.05% 335
2022
Q1 		$88K Sell
3,968
-232
-6% -$5.92K 0.04% 322
2021
Q4 		$183K Sell
4,200
-4,495
-52% -$180K 0.07% 242
2021
Q3 		$290K Sell
8,695
-458
-5% -$13.9K 0.13% 203
2021
Q2 		$252K Buy
9,153
+1,885
+26% +$39.3K 0.1% 209
2021
Q1 		$146K Buy
7,268
+135
+2% +$3.94K 0.06% 346
2020
Q4 		$235K Buy
+7,133
New +$190K 0.1% 327

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Virtus ETF Advisers's INBX Position: Q2 2024 in Review

Virtus ETF Advisers sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 3,143 shares — an estimated $110K sold.

Virtus ETF Advisers first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $290K in Q3 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Virtus ETF Advisers reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 3,143 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $110K.
  • Virtus ETF Advisers first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Virtus ETF Advisers's Inhibrx, Inc. Common Stock position peaked at $290K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.